Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 31Terminated 13Withdrawn 6Active not recruiting 4Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 1Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Transplantation × Clear all
NCT00449319 2017-11-17

LAM99P

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase NA Unknown
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00327314 2006-12-28

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Azienda Ospedaliera San Giovanni Battista

Phase 2 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡